Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Comparison Between Conventional Respiratory Physiotherapy and the Simeox Device in Patients With Bronchiectasis

A legfontosabb adatok

Ki végzi
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Hol
Olaszország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
40 fő, tervezett
Kezdés
2024. dec. 1.
Várható befejezés
2026. dec. 1.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • Simeox
A regiszteradat frissítve
2026. március 2.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with bronchiectasis not caused by cystic fibrosis, who are not in hospital. It compares standard breathing physiotherapy with the Simeox device.

Életkor
18 years and older
Nem
All sexes
A betegség stádiuma
Bronchiectasis (widened airways) seen in at least one lung lobe on a chest CT scan from the last 10 years. No flare-ups in the 28 days before joining. Coughing up sputum of 200 mL/day or less.
Korábbi kezelés
Must be on optimized standard therapy for bronchiectasis, stable for at least one year, with no changes in the 28 days before joining. Must be able to have, or already be having, breathing physiotherapy.

A részvétel fő kizáró okai

  • COPD or asthma as the main disease rather than bronchiectasis
  • Having a tracheostomy (breathing opening in the neck)
  • Major coughing up of blood (300 mL or more), or needing embolization or blood transfusions, in the 4 weeks before joining
  • Unstable circulation (mean arterial pressure < 65 mmHg, heart rate > 110 bpm) or an undrained collapsed lung (pneumothorax)
  • Pregnant or breastfeeding women

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki vehet részt

  • Patients with a diagnosis of bronchiectasis not due to cystic fibrosis who are not hospitalized
  • Age ≥ 18 years
  • Evidence of bronchiectasis in at least one lung lobe from a chest CT scan performed within the 10 years prior to enrollment
  • Absence of exacerbations in the 28 days preceding enrollment
  • Sputum producers with volumes less than or equal to 200 mL/day
  • Under treatment with optimized standard therapy for bronchiectasis that has been stable for at least one year, with no changes in the 28 days prior to enrollment
  • Eligible for and/or already undergoing respiratory physiotherapy
  • Signed informed consent

Ki nem vehet részt

  • Diagnosis of COPD or bronchial asthma interpreted as primary and predominant diseases compared to bronchiectasis
  • History of significant hemoptysis (≥300 mL of blood) or requiring embolization or blood transfusions in the 4 weeks preceding enrollment
  • Hemodynamic instability (mean arterial pressure < 65 mmHg, heart rate > 110 bpm)
  • Presence of tracheostomy
  • Undrained pneumothorax (evident on chest X-ray, deemed not worthy of pleural drainage according to standard clinical-assistance pathways and thus subjected to follow-up)
  • Women who are pregnant or breastfeeding

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Physiotherapy is a key treatment for patients with bronchiectasis. An evaluation of the parameters indicative of respiratory health in patients treated with two different respiratory physiotherapy techniques (conventional versus Simeox®) would be very useful in choosing physiotherapy treatments for bronchiectasis patients. A systematic review of the literature shows that there are no published studies evaluating the effectiveness of respiratory physiotherapy by analyzing the variation in resistance measured using the forced oscillation technique (FOT) in patients with bronchiectasis. The results of this study would add to those that have examined different physiotherapy techniques and could therefore contribute to the choice of the most appropriate technique for this category of patients.

A teljes eredeti leírásKevesebb

The trial is being conducted to answer the question: "How do respiratory parameters vary during treatment with two different respiratory physiotherapy techniques: conventional respiratory physiotherapy or that performed using the Simeox device?" Secondary objectives include the measurement of various functional parameters, such as vital signs (heart rate, respiratory rate, blood oxygenation, blood pressure values) and spirometry values (FEV1, FVC, TLC). The onset of adverse events, the degree of patient tolerance and relief, and respiratory health will also be assessed through the administration of various questionnaires commonly used in clinical practice. Additionally, changes in the quantity of sputum produced will be measured.

A vizsgálat 2 csoportja

  • Arm AEgyéb csoport

    Patients randomized to Group A will undergo the first treatment with conventional respiratory physiotherapy techniques (usually with Acapella, PEEP bottle, PEP mask, according to the standard clinical-assistance practice at our clinic and they will switch to Simeox for the second treatment

    Kezelés: Simeox

  • Arm BEgyéb csoport

    Patients randomized to Group B will undergo the first treatment with Simeox, and they will switch to conventional respiratory physiotherapy techniques (usually with Acapella, PEEP bottle, PEP mask, according to the standard clinical-assistance practice at our clinicfor the second treatment

    Kezelés: Simeox

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Comparison Between Different Respiratory Physiotherapy Techniques in Patients With Bronchiectasis. Conventional Therapy Versus Simeox: a Single-center, Randomized, Controlled, Cross-over Study
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. március 2.